Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Plexin-B3 ELISA Kit (AC2639)
Cat.#: ASET-1228
Specifications
Description Human Plexin-B3 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Plexin-B3 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 2.23 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 40-640 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1844 Human PSD95 ELISA Kit (AC3255) Quantitative inquiry ASET-1147 Human AANAT ELISA Kit (AC2558) Quantitative inquiry ASET-2083 Human NCAM2 ELISA Kit (AC3494) Quantitative inquiry ASET-2030 Human p75 NGF Receptor ELISA Kit (AC3441) Quantitative inquiry ASET-2535 Mouse Kappa Opioid Receptor ELISA Kit (AC3946) Quantitative inquiry ASET-2461 Human GRIP1 ELISA Kit (AC3872) Quantitative inquiry ASET-1893 Mouse Contactin 1 ELISA Kit (AC3304) Quantitative inquiry ASET-1078 Human NPTX2 ELISA Kit (AC2489) Quantitative inquiry ASET-1252 Human Granuphilin ELISA Kit (AC2663) Quantitative inquiry ASET-1763 Human IMPA1 ELISA Kit (AC3174) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket